Biotech Values

[Solar_Express]

Last week, under FDA approval, the drug leronlimab was tested in patients with serious respiratory conditions with Covid-19 in NY

https://seekingalpha.com/article/4334730-cytodyn-may-be-one-of-first-biotechs-to-drug-helps-against-covidminus-19

The respiratory condition that is so dangerous in Covid-19 results from a condition called a "cytokine storm." CytoDyn (OTCQB:CYDY) believes that filling the CCR5 receptor with a harmless monoclonal body will prevent further damage.



Authors Comment
Thomas Barnard
Comments174 | + Follow
Author’s reply »
Leronlimab may be useful for extreme cases with the cytokine storms, but many of us older folks are hoping that companies like Generex (GNBT) will stay the course because the epidemiologists say this disease is now out in the general population from here forward. Generex's Ii-key technology may be one of the best for vaccine development, which could save us from catching one of these horrible cases.